Clinical Trial Keywords
National Cancer Institute; Gynecologic Oncology Group
Selected Publications
View all on PubMed
Tanner E, Zahurak M, Bristow R, Diaz-Montes T. Outcomes of Younger Patients with Ovarian Cancer. Gynecol Oncol. 2008; 111(2): 221-5. PMID: 18786718.
Tanner E, Chi D, Eisenhauer E, Diaz-Montes T, Santillan A, Bristow R. Early Detection of Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer: Survival Benefit or Lead Time Bias. Gynecol Oncol. 2010; 117(2):336-40. PMID: 20153027.
Pant A, Diaz-Montes T, Tanner E, Ahmad S, Giuntoli R, Holloway R, Bristow R. Correlation of Extreme Drug Resistance Assay Results and Progression Free Survival Following Intraperitoneal Chemotherapy for Advanced Ovarian Cancer. J Chemother. 2010; 22(4): 270-4. PMID: 20685633.
Shih K, Qin L-X, Tanner E, Zhou Q, Bisogna M, Dao F, Olvera N, Viale A, Barakat R, Levine D. A MicroRNA Survival Signature (MiSS) for Advanced Ovarian Cancer. Gynecol Oncol. 2011; 121 (3): 444-50. PMID: 21354599.
Tanner E, Leitao M, Garg K, Chi D, Sonoda Y, Gardner G, Barakat R, Jewell E. The Role of Cytoreductive Surgery for Newly Diagnosed Advanced-Stage Uterine Carcinosarcoma. Gynecol Oncol. 2011; 123 (3): 548-52. PMID: 21945551.
Tanner E, Black D, Zivanovic O, Kehoe S, Dao F, Konner J, Barakat R, Lichtman S, Levine D. Patterns of First Recurrence Following Adjuvant Intraperitoneal Chemotherapy for Stage IIIC Ovarian Cancer. Gynecol Oncol. 2012; 124 (1): 59-62. PMID: 21982046.
Tanner E, Long K, Zhou Q, Brightwell R, Gardner G, Abu-Rustum N, Leitao M, Sonoda Y, Chi D. Impact of Operative Start Time on Surgical Outcomes in Patients Undergoing Primary Cytoreduction for Advanced Ovarian Cancer. Gynecol Oncol. 2012; 126 (1): 58-63. PMID: 22507533.
Hyman D, Long K, Tanner E, Grisham R, Arnold A, Bhatia J, Spriggs D, Soslow R, Kauff N, Levine D. Outcomes of Primary Surgical Cytoreduction in Patients with BRCA-associated High-grade Serous Ovarian Carcinoma. Gynecol Oncol. 2012; 126 (2): 224-8. PMID: 22579790.
Tanner E, Garg K, Leitao M, Soslow R, Hensley M. High Grade Undifferentiated Uterine Sarcoma: Surgery, Treatment, and Survival Outcomes. Gynecol Oncol. 2012; 127 (1): 27-31. PMID: 22750260.
Tanner E, Long K, Feffer J, Leitao M, Abu-Rustum N, Barakat R, Chi D, Gardner G. Parenchymal Splenic Metastasis is an Independent Negative Predictor of Overall Survival in Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer. Gynecol Oncol. 2012; 128 (1): 28-33. PMID: 23017819.
Tanner E, Toussaint T, Leitao M, Hensley M, Soslow R, Gardner G, Jewell E. Management of uterine adenosarcomas with and without sarcomatous overgrowth. Gynecol Oncol. 2013; 129 (1): 140-4. PMID: 23283300.
Sandadi S, Tanner E, Khoury-Collado F, Kostolias A, Makker V, Chi D, Sonoda Y, Alektiar K, Barakat R, Abu-Rustum N. Radical surgery with individualized postoperative radiation for stage IB cervical cancer: oncologic outcomes and severe complications. Int J Gynecol Oncol. 2013; 23 (3): 553-8. PMID: 23392402.
Barlin J, Long K, Tanner E, Gardner G, Leitao M, Levine D, Sonoda Y, Abu-Rustum N, Chi D. Optimal (≤1cm) but Visible Residual Disease: Is Extensive Debulking Warranted? Gynecol Oncol. 2013; 130 (2): 284-8. PMID: 23672929.
Ricci S, Giuntoli R, Eisenhauer E, Lopez M, Krill L, Tanner E, Gehrig P, Havrilesky L, Secord A, Levinson K, Frasure H, Celano P, Fader A. Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma? Gynecol Oncol. 2013; 131 (3): 629-33. PMID: 24016408.
Long K, Tanner E, Frey M, Leitao M, Levine D, Gardner G, Sonoda Y, Abu-Rustum N, Barakat R, Chi D. Intraoperative hypothermia during primary surgical cytoreduction for advanced ovarian cancer: Risk factors and associations with postoperative morbidity. Gynecol Oncol. 2013; 131(3): 525-30. PMID: 24016410.
Scheib S, Tanner E, Green I, Fader A. Laparoscopy in the Morbidly Obese: Physiologic Considerations and Surgical Techniques to Optimize Success. J Minim Invasive Gynecol. 2013; 21 (2): 182-95. PMID: 24100146.
Fader A, Java J, Krivak T, Bristow R, Tergas A, Bookman M, Armstrong D, Tanner E, Gershenson D. The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: A Gynecologic Oncology Group study. Gynecol Oncol. 2014; 132(3):560-5. PMID: 24333362.
Sinno A, Fader A, Long K, Giuntoli R, Tanner E. A Comparison of Colorimetric versus Fluorometric Sentinel Lymph Node Mapping During Robotic Surgery for Endometrial Cancer. Gynecol Oncol. 2014; 134 (2): 281-6. PMID: 24882555.
Suidan R, St. Clair C, Lee S, Barlin J, Long Roche K, Tanner E, Sonoda Y, Barakat R, Zivanovic O, Chi D. A comparison of primary intraperitoneal chemotherapy to consolidation intraperitoneal chemotherapy in optimally resected advanced ovarian cancer. Gynecol Oncol. 2014; 134 (3): 468-72. PMID: 25042672.
Cripe J, Tseng J, Eskander R, Fader A, Tanner E, Bristow R. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Carcinoma: Analysis of 30-Day Morbidity and Mortality. Ann Surg Oncol. 2014; 22(2): 655-61. PMID: 25155402.
Suidan R, Zhou Q, Iasonos A, O'Cearbhaill R, Chi D, Long Roche K, Tanner E, Denesopolis J, Barakat R, Zivanovic O. Prognostic Significance of the Number of Postoperative Intraperitoneal Chemotherapy Cycles for Patients With Advanced Epithelial Ovarian Cancer. Int J Gynecol Cancer. 2015; 25(4): 599-606. PMID: 2566443
Sinno A, Fader A, Tanner E. Single Site Robotic Sentinel Lymph Node Biopsy and Hysterectomy in Endometrial Cancer. Gynecol Oncol. 2015; 137(1): 190. PMID: 25684218
Kushnir C, Angarita A, Havrilesky L, Thompson S, Spahlinger D, Sinno A, Tanner E, Secord A, Roche K, Stone R, Fader A. Selective Cardiac Surveillance in Patients with Gynecologic Cancer Undergoing Treatment with Pegylated Liposomal Doxorubicin (PLD). Gynecol Oncol. 2015; 137(3): 503-7. PMID: 25735254.
Tanner E, Sinno A, Stone R, Levinson K, Long K, Fader A. Factors Associated with Successful Bilateral Sentinel Lymph Node Mapping in Endometrial Cancer. Gynecol Oncol. 2015; [epub ahead of print]. PMID: 26095896.
Sinno A, Tanner E. Robotic Laparoendoscopic Single Site Radical Hysterectomy with Sentinel Lymph Node mapping and Pelvic Lymphadenectomy for Cervical Cancer. Gynecol Oncol. 2015; [epub ahead of print]. PMID: 26307401.
Cholakian D, Hacker K, Fader A, Gehrig P, Tanner E. Effect of Oral Versus Intrauterine Progestins on Weight in Women Undergoing Fertility Preserving Therapy for Complex Atypical Hyperplasia or Endometrial Cancer. Gynecol Oncol 2015; [epub ahead of print].
Fader A, Weise R, Sinno A, Tanner E, Borah B, Moriarty J, Bristow R, Makary M, Pronovost P, Hutfless S, Dowdy S. Utilization of Minimally Invasive Surgery in Endometrial Cancer Care: A Quality and Cost Disparity. Gynecol Oncol 2015; [epub ahead of print]. PMID: 26646127.
Patient Ratings & Comments
The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.